KKR has acquired a majority stake in HealthCare Royalty Partners, pushing the investment firm further into the healthcare ...

Investment firm KKR (NYSE:KKR) announced on Wednesday the acquisition of a majority stake in biopharma royalty acquisition company, HealthCare Royalty Partners. The acquisition marks KKR's expansion ...

KKR & Co. Inc., a leading global investment firm, today announced that it has acquired a majority ownership stake in HealthCare Royalty Partners (HCRx), a leading biopharma royalty acquisition company ...

As part of the transaction, HCRx Chairman and CEO Clarke Futch will continue to lead the HCRx team and will maintain an ongoing substantial minority interest in HCRx.

KKR executives said strong momentum in their business gave them confidence on Thursday of beating earnings targets for 2026, ...

Detailed price information for KKR & Company LP (KKR-N) from The Globe and Mail including charting and trades.

KKR is no longer involved with Quorum, according to its website. Locally, KKR is also involved with Covenant Physician Partners and owns property at 2300 Elm Hill Pike, for which it paid $21.14 ...

SEE ALSO: Sunday Summary: Still Trying to Figure Out the Politics of It The new fund is projected to eventually reach a value of more than $1 billion. As part of the joint venture, Healthcare Realty ...